Halozyme Therapeutics, Inc. (HALO) Misses Q4 EPS by 3c; Roche (RHHBY) Triggers $4M Milestone
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 130.34 +1.72 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.62 | 52 Week High | $18.39 | |||
| Open | $130.81 | 52 Week Low | $6.96 | |||
| Day High | $130.98 | P/E | N/A | |||
| Day Low | $126.86 | EPS | $-0.58 | |||
| Volume | 1,589,124 | |||||
| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 60.94 +1.76 (2.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.18 | 52 Week High | $35.13 | |||
| Open | $60.30 | 52 Week Low | $28.10 | |||
| Day High | $61.04 | P/E | N/A | |||
| Day Low | $59.88 | EPS | $0.00 | |||
| Volume | 1,099,571 | |||||
